2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "ALARICE Study - Avelumab With Axitinib in Persistent/Recurrent Cervical Cancer After Platinum-Based Chemo"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Ka Yu Tse
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Ka Yu Tse
Comments 0
Login to view comments.
Click here to Login